Semax
Semax is a synthetic heptapeptide derived from the ACTH(4-10) fragment and modified with a stabilizing C-terminal Pro-Gly-Pro sequence. Originally developed in Russia, Semax is described in research literature as a nootropic and neuroprotective peptide with reported effects on cognitive pathways, neuroplasticity, stress response, and neuronal signaling.
It is studied for its potential influence on melanocortin pathways and its ability to modulate expression of genes involved in neuroprotection, oxidative stress balance, and synaptic plasticity.
Mechanism of Action
(Mechanistic descriptions from published research; not clinical claims.)
- Melanocortin system modulation — Partial agonist/antagonist activity at MC4 and MC5 receptors with MC3 sparing.
- BDNF/TrkB upregulation — Increases BDNF levels and TrkB phosphorylation, supporting synaptic plasticity.
- Neurotransmitter modulation — Influences serotonergic and dopaminergic pathways.
- Immunomodulation — Reduces inflammatory cytokine expression in neural tissue.
- Enkephalinase inhibition — Prolongs endogenous neuropeptide signaling.
- Calcium homeostasis modulation — Regulates intracellular Ca²⁺ signaling to support neuroprotection.
$38.00
Per Unit
In stock